Established in 2016, Abryl Laboratories was founded with the sole objective of supplying the global market with top-notch sterile liquid and lyophilised products. Over time, Abryl has broadened its activities to include pre-filled syringes. The initiative was conceived in 2016, and construction began in 2017. By May 2019, just two years later, the facility was fully prepared to commence operations. Spanning an extensive area of 22342 square meters, the company premises consist of a production block and a dedicated R&D building.